Original Article

Mod Pathol 2001;14(7):650–654

The Prognostic Significance of P-Cadherin in Infiltrating Ductal Breast Carcinoma

Carlos Gamallo M.D.1, Gema Moreno-Bueno Ph.D.2, David Sarrió Ph.D.2, Francisco Calero M.D.3, David Hardisson M.D.4 and José Palacios M.D.2

  1. 1Servicio de Anatomía Patológica, Hospital Universitario de La Princesa, Madrid, Spain
  2. 2Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas (CNIO) Carlos III, Hospital Universitario La Paz, Madrid, Spain
  3. 3Departamento de Obstetricia y Ginecología, Hospital Universitario La Paz, Madrid, Spain
  4. 4Anatomía Patológica, Hospital Universitario La Paz, Madrid, Spain

Correspondence: José Palacios, M.D., Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas Carlos III, Instituto de Salud Carlos III, Ctra Majadahonda-Pozuelo, Km 2. 280220 Majadahonda Madrid, Spain. e-mail: jpalacios@cnio.es; fax: 34-91- 509-70-52

Accepted 27 February 2001.

Top

Abstract

We have immunohistochemically investigated P-cadherin (P-CD) expression in a series of 210 infiltrating ductal carcinomas (IDC) in an attempt to assess the biological and prognostic relevance of P-CD in patients harboring IDCs. Although only 74/210 (35%) of IDCs expressed P-CD in >5% of tumor cells (P-CD–positive carcinomas), categorical analyses revealed that P-CD–positive IDCs were larger (26 plusminus 21 cm versus 22 plusminus 11 cm, P = .0568), of higher histological grade (P = .0001), and had more lymph node metastases (P = .0327) than P-CD–negative breast carcinomas. In addition, P-CD–positive tumors were negative for estrogen (P = .0001) and progesterone receptors (P = .0001) and showed reduced E-cadherin expression (P = .0276) more frequently than P-CD–negative tumors. Univariate analysis carried out in 171 patients demonstrated that P-CD expression was also an indicator of poor prognosis (chi2 = 8.292, P = .004), extent of lymph node metastasis (chi2 = 20.854, P = .0000), histological grade (chi2 = 12.908, P = .0016), and negative progesterone receptors (chi2 = 4.116, P = .042). However, only histological grade and nodal metastases emerged as independent prognostic markers in the multivariate analysis. These results suggest that although P-CD expression may be involved in the progression of IDCs, its value as an independent prognostic factor remains to be established.

Keywords:

Breast cancer, E-cadherin, P-cadherin, Prognosis, Tumor progression

Extra navigation

.

naturejobs

ADVERTISEMENT